Abstract
Corticosteroids have been proposed for decades as adjunctive therapy of severe infections. These drugs have complex mechanisms of action involving anti-inflammatory and vasoactive properties. However, due to discordant results from clinical studies, the use of corticosteroids to treat patients with severe infections is still a matter of intense debate in the scientific and medical community. In the present article, we review the underlying mechanisms related to the potential benefits of corticosteroids and their impact on clinical management of severe sepsis.
Keywords: Bacterial infections, glucocorticoids, sepsis, septic shock, therapeutics
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title: Corticosteroids in Sepsis: Pathophysiological Rationale and the Selection of Patients
Volume: 10 Issue: 3
Author(s): Jorge Ibrain Figueira Salluh, Fernando Augusto Bozza, Andre Miguel Japiassu, Hugo Caire Castro Faria Neto, Patricia Torres Bozza and Pedro Povoa
Affiliation:
Keywords: Bacterial infections, glucocorticoids, sepsis, septic shock, therapeutics
Abstract: Corticosteroids have been proposed for decades as adjunctive therapy of severe infections. These drugs have complex mechanisms of action involving anti-inflammatory and vasoactive properties. However, due to discordant results from clinical studies, the use of corticosteroids to treat patients with severe infections is still a matter of intense debate in the scientific and medical community. In the present article, we review the underlying mechanisms related to the potential benefits of corticosteroids and their impact on clinical management of severe sepsis.
Export Options
About this article
Cite this article as:
Ibrain Figueira Salluh Jorge, Augusto Bozza Fernando, Miguel Japiassu Andre, Caire Castro Faria Neto Hugo, Torres Bozza Patricia and Povoa Pedro, Corticosteroids in Sepsis: Pathophysiological Rationale and the Selection of Patients, Endocrine, Metabolic & Immune Disorders - Drug Targets 2010; 10 (3) . https://dx.doi.org/10.2174/187153010791936865
DOI https://dx.doi.org/10.2174/187153010791936865 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroprotective Strategies in Glaucoma
Current Pharmaceutical Design Monoamine Oxidases: to Inhibit or Not to Inhibit
Mini-Reviews in Medicinal Chemistry Functional Signaling Biases in G Protein-Coupled Receptors: Game Theory and Receptor Dynamics
Mini-Reviews in Medicinal Chemistry Monoclonal Antobodies: Application in Radiopharmacy
Current Radiopharmaceuticals Chemistry and Biology of Cyperus scariosus: An Overview
Current Chemical Biology Does Daily Dialysis Improve Hypertension in Chronic Haemodialysis Patients?
Current Hypertension Reviews Alumina Sulfuric Acid: An Efficient Heterogeneous Catalyst for the Synthesis of Amidoalkyl Naphthols
Letters in Organic Chemistry MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug Resistance
Current Drug Targets Older and Newer Strategies for the Pharmacological Management of Agitation in Patients with Bipolar Disorder or Schizophrenia
CNS & Neurological Disorders - Drug Targets Ethanol Withdrawal and Hyperalgesia
Current Drug Abuse Reviews Effects of <i>Nigella Sativa</i> (Black seeds) Supplementation on Plasma Lipid Profile in Human Subjects - A Review
Current Nutraceuticals Non-IgE Mediated Food Allergy – Update of Recent Progress in Mucosal Immunity
Inflammation & Allergy - Drug Targets (Discontinued) The Evolution of Pharmacological Treatment for Parkinsons Disease
Recent Patents on CNS Drug Discovery (Discontinued) Interaction Between Bone and Muscle in Older Persons with Mobility Limitations
Current Pharmaceutical Design Hypertension in the Elderly: An Evidence-based Review
Current Pharmaceutical Design Monoclonal Antibodies as Cancer Therapeutics
Recent Patents on Biotechnology Differentiating the Dementias. Revisiting Synucleinopathies and Tauopathies
Current Alzheimer Research Cannabinoids as Neuroprotective Agents in Traumatic Brain Injury
Current Pharmaceutical Design Mast Cells: Target and Source of Neuropeptides
Current Pharmaceutical Design Targeting Nanoparticles as Drug Delivery Systems for Cancer Treatment
Current Nanoscience